HighVista Strategies LLC

Position in IMVT — Immunovant, Inc.

CIK 1335325 BOSTON, MA

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,706,446

+$5,113,994 QoQ

Shares Held

277,873

+23.4% QoQ

Ownership

0.135%

of shares outstanding

% of Portfolio

2.45%

of 13F equity value

Holder Rank

#41

of 223 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighVista Strategies LLC holds $278,365,756 across 70 Biotechnology names. IMVT ranks #4 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	113,031	$15,062,511
2	RVMD	Revolution Medicines, Inc.	66,983	$12,544,576
3	DFTX	Definium Therapeutics, Inc.	242,884	$11,425,263
4	IMVT	Immunovant, Inc. This page	277,873	$10,706,446
5	PRAX	Praxis Precision Medicines, Inc.	30,210	$10,114,005
6	RLAY	Relay Therapeutics, Inc.	506,235	$9,471,656
7	PCVX	Vaxcyte, Inc.	149,739	$8,704,328
8	TNGX	Tango Therapeutics, Inc.	260,070	$8,129,788

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,706,446	277,873	+23.4%	Shares	Sole	2026-08-14
2026-03-31	$5,592,452	225,139	+1.5%	Shares	Sole	2026-05-15
2025-12-31	$5,640,265	221,883	-12.3%	Shares	Sole	2026-02-17
2025-09-30	$4,080,407	253,127	+38.5%	Shares	Sole	2025-11-14
2025-06-30	$2,924,928	182,808	+91.1%	Shares	Sole	2025-08-14
2025-03-31	$1,634,624	95,648	-21.1%	Shares	Sole	2025-05-15
2023-12-31	$5,109,821	121,287	+13.4%	Shares	Sole	2024-02-14
2023-09-30	$4,104,198	106,908	-40.7%	Shares	Sole	2023-11-14
2023-06-30	$3,420,670	180,320	+10.1%	Shares	Sole	2023-08-14
2023-03-31	$2,540,522	163,799	+814.8%	Shares	Sole	2023-05-15
2020-12-31	$827,031	17,905	0.0%	Shares	Sole	2021-02-16
2020-09-30	$630,076	17,905	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.